Lv31
284 积分 2026-04-01 加入
Optimizing Pharmacokinetics-Pharmacodynamics of Antimicrobial Management in Patients with Sepsis: A Review
2天前
已完结
State of the Management of Infections Caused by Multidrug-Resistant Gram-Negative Organisms
2天前
已完结
Dose tapering to withdrawal stage and long‐term efficacy and safety of hetrombopag for the treatment of immune thrombocytopenia: Results from an open‐label extension study
8天前
已完结
Avatrombopag for adult chronic primary immune thrombocytopenia: a randomized phase 3 trial in China
8天前
已完结
Phase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia
8天前
已完结
The 2025 guidance on the surveillance and control of Candida infections: Recommendations from the China invasive fungal surveillance net (CHIF-NET) study group
19天前
已完结
A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia
22天前
已完结
Repeated short‐term use of eltrombopag in patients with chronic immune thrombocytopenia (ITP)
22天前
已完结
Wong RSM, Saleh MN, Khelif A, et al. Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study. Blood. 2017;130(23):2527-2536
22天前
已完结
Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study
22天前
已完结
皖公网安备34019202002308
